(Q44491535)

3 December 2017

title

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches (English)

1 reference

3 December 2017

0 references

0 references

George L Bakris

1

1 reference

3 December 2017

Matthew R Weir

series ordinal

2

1 reference

3 December 2017

Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators

series ordinal

3

1 reference

3 December 2017

publication date

1 May 2003

1 reference

Journal of Clinical Hypertension

3 December 2017

published in

1 reference

3 December 2017

volume

5

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

202-209

1 reference

Diabetes, hypertension, and cardiovascular disease: an update

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Hypertension and diabetes: new therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

The prevention or delay of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Treatment of hypertension in patients with type 2 diabetes: a review of the recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

The role of combination therapy in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

A practical approach to achieving recommended blood pressure goals in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Pharmacoeconomics of hypertension management: the place of combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Diuretics and beta-blockers: is there a risk for dyslipidemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2002.2041.X

10.1111/J.1524-6175.2002.2041.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference